Literature DB >> 9088868

Structure-activity relationship of quaternary ion antagonism of levcromakalim-induced relaxation in pig coronary artery.

A E Piekarska1, G A McPherson.   

Abstract

The aim of this study was to investigate the interaction between the K+ channel opener levcromakalim and several quaternary ions. Cumulative vasorelaxant-response curves to levcromakalim were constructed in the absence and in the presence of the quaternary ions, in the pig coronary artery. The most potent compounds (based on 'apparent pKB' values) were: propyltriphenylphosphonium (7.33), butyltriphenylphosphonium (7.04), tetraphenylarsonium (6.86), tetraphenylphosphonium (6.81), ethyltriphenylphosphonium (6.70), and hexyltriphenylphosphonium (6.63). Tetrabutylphosphonium (6.06), tetrabutylammonium (5.12), methyltriphenylphosphonium (5.25), clofilium (5.66) and guanethidine (5.61) were significantly less potent. Tetrapropylammonium, tetrapentyltin and tetraphenylboron were inactive at the maximum concentrations used (30 microM). Tetraphenylboron (10-100 microM) fully reversed tetraphenylphosphonium, tetraphenylarsonium (both at 3 microM), tetrabutylammonium (30 microM) and clofilium (10 microM) and partially reversed guanethidine (10 microM) antagonism of levcromakalim responses indicating a similarity in the mechanism of action of these chemically distinct compounds. The results show that quaternary ions similar in structure to tetraphenylphosphonium, i.e., containing phosphonium ion centre and phenyl side chains, are the most potent antagonists of levcromakalim, in pig coronary artery. It is also apparent that marked changes can be made in the substitution on the phosphonium ion (ethyl to hexyl) with little or no effect on their potency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088868     DOI: 10.1016/s0014-2999(96)00979-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Functional and electrophysiological effects of a novel imidazoline-based K(ATP) channel blocker, IMID-4F.

Authors:  G A McPherson; K L Bell; J L Favaloro; M Kubo; N B Standen
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Phosphonium compounds as new and specific inhibitors of bovine serum amine oxidase.

Authors:  Maria Luisa Di Paolo; Michele Lunelli; Marina Scarpa; Adelio Rigo
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

3.  Novel imidazoline compounds that inhibit Kir-mediated vasorelaxation in rat middle cerebral artery.

Authors:  Joanne L Favaloro; Karen L Andrews; Grant A McPherson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-27       Impact factor: 3.000

4.  Vasorelaxation and hyperpolarisation of rat small mesenteric artery by the quaternary anion tetraphenylboron.

Authors:  Joanne L Favaloro; Grant A McPherson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-03-19       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.